Company / Current Liabilities
Sana Biotechnology, Inc. Current Liabilities History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$45.4M
FY2024
5-year range
$31.5M / $111.5M
FY2020-FY2024
Trend
-29.5%
vs FY2023
Sector context
#150 of 213
Health Care
What the data says
At $45M, Sana Biotechnology, Inc.'s current liabilities ranks #64 of 213 in the Health Care sector. Improved from $112M to $45M over the past 2 years.
Based on SEC 10-K filings.
$45M in FY2024 with a 3-year CAGR of -22.9%.
Improved from $112M to $45M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -22.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#64 of 213 in Health CareTop 30% of 213This company $45.4M Sector average $1.6B
▼
-97.1% below sector average
Key checks
Key Insights
- 3-year CAGR of -22.9%, indicating a declining trend.
- In FY2024, current liabilities decreased 29.5% year-over-year.
- Ranks #150 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $45.4M | -29.5% |
| FY2023 | $64.5M | -42.2% |
| FY2022 | $111.5M | +12.4% |
| FY2021 | $99.2M | +215.5% |
| FY2020 | $31.5M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026